Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?

ABSTRACT:

Objectives

To assess the clinical significance of repeat transurethral resection (reTUR) and surgical margin status after en bloc resection of bladder tumour (ERBT) for pathological T1 (pT1) bladder cancer.

Patients and methods

We retrospectively analysed the record of 106 patients with pT1 high-grade bladder cancer who underwent ERBT between April 2013 and February 2021 at multiple institutions. All specimens were reviewed by a genitourinary pathologist. The primary outcome measures were recurrence-free survival (RFS) and progression-free survival (PFS) between patients with and those without reTUR. We also analysed the predictive value of surgical margin on the likelihood of residual tumour on reTUR.

Results

A reTUR was performed in 50 of the 106 patients. The 2-yea

SUBMITTER: Yanagisawa T 

PROVIDER: S-EPMC10084154 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature